New studies look into just how the body art of tattooing can benefit a diabetic person; while another study finds the link between tattoo ink and cancer.

A 35-year-old Frenchman who had been in a vegetative state for the last 15 years after a car accident, recently showed signs of awareness after having key brain regions electrically stimulated via the vagus nerve in the neck. This result proved wrong, the belief that patients who have been unconscious for more than a year, cannot be slightly conscious again.

Apple’s new Apple Watch Series 3 would be tackling more than just fitness and tech enthusiasts with its advanced heart rate monitor – aimed at detecting potential heart diseases.

In conjunction with World Heart Day, MIMS brings to you a collection of recent studies aimed at improving the treatment of heart diseases with the discovery of new treatments and detection method.

Leprosy is one of the oldest recorded diseases in human civilisation. Nonetheless, only in the past century have we discovered a cure for it. Even till this day, the global effort to combat leprosy continues – as we take a look at the history of this ancient plague.

Researchers in the UK have, for the first time, used CRISPR technology to identify the role of a key gene in human embryos.

Decoding the biological makeup of seven different types of medulloblastoma is crucial to develop more specific treatment.

A new malaria drug, developed by Tulane University, was proven effective in a FDA-supervised clinical trial. The molecule raised new hope in the combat against the drug-resistant strains of the parasite. But is it too good to be true?

In February 2018, there will soon be a new journal dedicated to CRISPR technology. It hopes that the editorials, analyses, debates and commentary surrounding the technology could drive more ground-breaking research to transform human lives. But critics have questioned over the necessity of another niche science journal. Will it stand out from existing major journals?

Latest research on women’s health have shed much more light in areas of pre-term labour, cervical cancer screening and hormone replacement therapy.

Genetic testing company, Invitae, has come under fire after an 11-month error in its test which went unchecked – affecting 50,000 test samples – that may be linked to an increased risk of cancer.